[Fundamental aspects: mechanisms of carcinogenesis and dose-effect relationship]

R Monier1

  • 1Laboratoire de génétique oncologique, UMR 1599 CNRS, Institut Gustave-Roussy, Villejuif, France. froyer@igr.fr

Insights

Cancer development (oncogenesis) involves accumulating genetic and epigenetic changes. Environmental factors and carcinogen exposure influence these events, impacting cancer risk and risk assessment strategies.

Area of Science:

  • Oncology
  • Genetics
  • Environmental Health

Context:

  • Oncogenesis is a multistep process driven by genetic and epigenetic alterations in a single cell.
  • Proto-oncogenes gain function (oncogenes), while tumor suppressor genes lose function.
  • Cellular mechanisms like apoptosis prevent malignant transformation, but genetic instability is crucial for cancer progression.

Purpose:

  • To elucidate the multistep nature of oncogenesis.
  • To explain the roles of genetic/epigenetic events, oncogenes, and tumor suppressor genes.
  • To discuss the influence of environmental factors and carcinogens on cancer development.

Summary:

  • Cancer arises from accumulated genetic and epigenetic events, altering key genes.
  • Multiple genetic events, potentially up to seven or eight for solid tumors, are implicated.
  • Behavioral and environmental factors, including chemical carcinogens, increase oncogenic event probability.

Impact:

  • Understanding oncogenesis is vital for cancer prevention and treatment strategies.
  • Dose-effect relationships for carcinogens inform risk assessment and regulatory policies.
  • Distinguishing between genotoxic and non-genotoxic carcinogens is critical for human exposure guidelines.

Related Concept Videos

What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...